NEW YORK (GenomeWeb) – Invitae announced today that it has acquired privately owned data company AltaVoice. Under the terms of the deal, Invitae purchased all of AltaVoice's stock in exchange for $5 million in Invitae common stock and up to an additional $10 million in Invitae common stock if certain future milestones are met.

The acquisition will add to Invitae's Genome Network, the company said, which connects patients, clinicians, advocacy organizations, researchers, and pharma companies to advance the understanding of hereditary disease and its possible treatments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.